Entero Therapeutics, Inc.
ENTO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,059 | -$15,795 | -$14,630 | -$58,538 |
| Dep. & Amort. | $49 | $29 | $29 | $542 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $632 | $1,040 | $769 | $1,371 |
| Change in WC | $2,529 | $2,190 | -$10,502 | $17,101 |
| Other Non-Cash | $5,632 | $157 | $277 | $3,463 |
| Operating Cash Flow | -$9,218 | -$12,378 | -$22,344 | -$32,288 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$500 | $0 | -$10,319 |
| Net Acquisitions | $88 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$10 |
| Investing Cash Flow | $88 | -$500 | $0 | -$10,319 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$645 | -$603 | -$641 | $89 |
| Stock Issued | $6,226 | $15,830 | $23,048 | $32,663 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1 | -$6,668 | $12,012 |
| Financing Cash Flow | $5,581 | $15,227 | $15,740 | $44,763 |
| Forex Effect | $0 | $0 | -$260 | $31 |
| Net Chg. in Cash | -$3,548 | $2,349 | -$6,864 | $2,187 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,733 | $1,384 | $8,249 | $6,062 |
| End Cash | $185 | $3,733 | $1,384 | $8,249 |
| Free Cash Flow | -$9,218 | -$12,878 | -$22,344 | -$42,608 |